Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Primary amino groups on stratum corneum proteins represent a significant chemical target for topical pharmacological and cosmetic agents. These groups, primarily located on the N-termini and lysine side chains of proteins such as keratin and filaggrin, are the reactive sites for dihydroxyacetone (DHA) in sunless tanning products (Source: Ciriminna et al., 2018, ChemistryOpen). In this process, they undergo a Maillard reaction to produce brown-colored melanoidins within the non-living layers of the epidermis (Source: J. Clin. Aesthet. Dermatol., 2009). In clinical dermatology, these amino groups are targeted by cross-linking agents like glutaraldehyde and formaldehyde to treat viral warts and hyperhidrosis by hardening the tissue and denaturing viral proteins (Source: British Journal of Dermatology, 1970). Furthermore, these reactive sites are central to the pathophysiology of allergic contact dermatitis, as many chemical allergens act as haptens that covalently bind to these amino groups to form complete antigens (Source: Toxicology, 2005). The accessibility and reactivity of these groups are critical factors in the design of topical drug delivery systems and the assessment of skin barrier integrity (Source: StatPearls, Physiology, Stratum Corneum, 2023). Understanding the density and distribution of these groups helps in predicting the penetration and efficacy of various dermatological treatments.
Covalent modification of protein residues, including the Maillard reaction (for tanning) and protein cross-linking (for wart treatment), to alter the physical or chemical properties of the skin's outermost layer.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Primary amino groups on stratum corneum proteins.